A stark divergence is defining Palantir Technologies. While the company posts explosive financial growth, its stock has been one of Wall Street’s most punishing trades this year, shedding over a quarter of its value since January. This contradiction between operational performance and market sentiment has investors grappling with a critical question: can the fundamentals ever justify the price?
The tension was on full display this week. After a brutal seven-day stretch that saw shares plummet roughly 14%, their worst weekly performance in a year, a partial rebound emerged on Monday. The stock climbed 3.3%, fueled by a dual catalyst. Former President Donald Trump praised the company on Truth Social, calling it an indispensable tool for national defense. Simultaneously, Cathie Wood’s ARK Invest deployed fresh capital, purchasing approximately 85,500 shares across five of its ETFs for an estimated $11 million.
This institutional vote of confidence stands in sharp contrast to other high-profile moves. In a dramatic shift, Peter Thiel’s hedge fund, Thiel Macro, liquidated all its public equity holdings in the fourth quarter of 2025—including positions in Nvidia, Tesla, Microsoft, and Apple—converting them into about $74 million in cash. Notably, Thiel remains a major personal shareholder as a co-founder, but chose to pull his fund completely from the market.
The internal picture is equally conflicted. Over the past three months, company insiders have sold shares worth $432.9 million without making a single purchase. On the institutional side, activity is mixed; while the Alaska Revenue Fund slightly reduced its stake, giants like Vanguard and State Street expanded their holdings.
Beneath the volatility, Palantir’s business engine is firing. Fourth-quarter 2025 revenue surged 70% year-over-year to $1.41 billion, with earnings per share of $0.25 beating expectations. Its U.S. commercial segment exploded by 137%, and government revenue grew 66% to $570 million. The company’s “Rule of 40” score, a key metric for software firms, hit an exceptional 127. For 2026, management forecasts revenue between $7.18 and $7.20 billion, implying another year of growth near 61%.
Should investors sell immediately? Or is it worth buying Palantir?
Yet, the valuation remains the central battleground. The stock trades at a towering 203 times earnings and 68 times sales. Based on projected 2026 profits, the multiple is still around 99. This leaves almost no room for error and has sparked a clear divide among prominent investors.
Wedbush analyst Dan Ives dismisses concerns about rising competition from AI rivals like Anthropic as a “fictional bear narrative,” maintaining an Outperform rating with a $230 price target. On the opposite side, Michael Burry of “The Big Short” fame holds put options with strike prices of $50 and $100 for 2026 and 2027, a direct bet that the current valuation is unsustainable.
Geopolitics add another layer of risk. More than half of Palantir’s U.S. revenue comes from government clients, including the Pentagon and Immigration and Customs Enforcement (ICE). Reports that its Maven Smart System AI targeting platform is being used by the U.S. military in the Middle East make the stock acutely sensitive to headlines, as last week’s sell-off on reports of potential Strait of Hormus tensions demonstrated.
An unresolved strategic question also lingers. CEO Alex Karp told CNBC the company would “gradually phase out” models from Anthropic, but has not yet executed the move. How Palantir’s competitive stance evolves will influence near-term trading.
With a market capitalization still above $300 billion, Palantir sits at a crossroads. The next quarterly report, expected in May, will show whether its commercial momentum can sustain the immense growth already priced into the shares. For now, the market is a theater of opposing convictions, with billions of dollars resting on which view proves correct.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from April 14 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 14.
Palantir: Buy or sell? Read more here...
